HeyJaredTobi Opeyemi Amure
- Indexed articles, last 90 days
- 14
- Latest publication
- Sep 30, 2026
- Outlet visibility, for Aol
- Top 5K sites
- Earliest in this view
- Aug 30, 2026
Latest articles
Zuckerberg lost $8.9 billion in one day: Your 401k may share the same risk - AOL (opens the original)
Read excerpt
A fortune built on stock can grow by billions before lunch and give a chunk of it back before the closing bell. That’s the trade-off that comes with owning a company instead of drawing a paycheck. You don’t need a billion dollars to feel it. If you own an S&P 500 index fund or a target-date fund in your 401(k), you already hold small slices of the tech giants now spending hundreds of billions of dollars on artificial intelligence. For most of September, those slices looked like a gift. Meta Plat
Gold and silver crash as 10-year yield tops 5.2% - AOL (opens the original)
Read excerpt
Every investor eventually learns that safety has a price. You just don’t always see the bill until it shows up. For most of the past two years, the bill for owning gold and silver looked tiny. The metals paid you nothing, but savings accounts and bonds paid so little that almost nobody cared. That math fueled one of the great precious-metals runs of our lifetimes. Gold broke past $5,000 an ounce and silver topped $100 in January, and millions of ordinary savers bought in as a shield against infl
Piper Sandler revamps Meta stock price target after cutting it 3 weeks ago - AOL (opens the original)
Read excerpt
Wall Street analysts hate looking wrong, but they hate looking late even more. A price target is supposed to be a 12-month estimate of where a stock should trade. In practice, it works more like a bookmark that gets moved whenever the story changes. Most of the time, those moves are small. An analyst trims $10 after a messy earnings call or adds $15 after a clean one, and almost nobody outside a trading desk notices. The big jumps come when a stock runs straight past the old number. At that poin
Bank of America has strong message for Merck stock investors - AOL (opens the original)
Read excerpt
Wall Street rarely pays for the same drug twice. Once a big trial succeeds, the stock jumps and investors start asking what comes next. That question gets louder when a company’s biggest product is heading toward a patent cliff. One hit can’t fill a revenue gap measured in tens of billions of dollars, so the pipeline has to keep producing. Investors usually get their answers on earnings calls or at medical meetings. Sometimes a smaller room tells them more. Private meetings between analysts and
Bank of America sees 43% upside in beaten-down ride-hailing giant - AOL (opens the original)
Read excerpt
New technology rarely kills an incumbent overnight. It usually takes years of slow share losses before the damage shows up in the numbers. Stock prices don’t wait that long. Investors tend to price in the worst case the moment a credible threat appears, long before customers actually switch. That gap between fear and reality is where some of the market’s biggest mispricings live. It is also where Wall Street analysts earn their keep, by putting hard numbers on a threat everyone can see but nobod
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 5K sites
For Aol, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.